CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. has a source-backed asset record in this dataset as of 2026-11-01.
- Country / operating region
- China
- Ticker
- 01228.HK
- Headquarters
- 查無
- Founded
- 查無
- Business
- Biopharmaceutical research and development
- Website
- www.canbridgepharma.com
Pipeline / products
| Asset | Registered / announced phase | Trial | Status | Sponsor | Record date |
|---|---|---|---|---|---|
| CAN108 (maralixibat) | Approved in China for ALGS (undated pipeline page) | — | 查無 | 查無 | 查無 |
Licensing deals
查無
Catalysts
查無
Latest monthly revenue
查無
Most advanced drug
查無
Drugnews analysis
查無